Company AB Science

AB

FR0010557264

Pharmaceuticals

Real-time Euronext Paris 12:52:26 04/11/26 am AEDT			5-day change	1st Jan Change
0.5280 ^EUR	-2.04%		-0.94%	-65.62%

10/10	AB Science S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05/10	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon

Business description: AB Science

AB Science specializes in research, development, and sales of kinase protein inhibitors (KPI), therapeutic drugs used in treating cancerous tumors, inflammatory and neuro-degenerative diseases in both humans and animals.

Number of employees: 33

Sales by Activity: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Pharmaceuticals	1.61M	958K	970K	1.07M	1.17M

See all business segments

Geographical breakdown of sales: AB Science

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Europe	-	-	-	-	955K
outside Europe	-	-	-	-	219K

See all geographic segments

Executive Committee: AB Science

Manager	Title	Age	Since
Stéphane Ledermann CEO	Chief Executive Officer	-	07/07/2026
Laurent Guy DFI	Director of Finance/CFO	-	20/11/2009
Christian Fassotte CTO	Chief Tech/Sci/R&D Officer	-	01/04/2018
Alexis Bernard PRN	Corporate Officer/Principal	-	-

See AB SCIENCE governance

Composition of the Board of Directors: AB Science

Director	Title	Age	Since
Alain Moussy CHM	Chairman	-	11/07/2001
Patrick Moussy BRD	Director/Board Member	-	20/09/2011
Cécile de Guillebon BRD	Director/Board Member	65	27/06/2021
Catherine Johnston-Roussillon BRD	Director/Board Member	68	27/06/2021
Guillemette Latscha BRD	Director/Board Member	-	27/06/2021
Stéphane Ledermann CHM	Chairman	-	07/07/2026

Composition of the Board of Directors

Shareholders: AB Science

Name	Stocks	%	Valuation
Jean-Claude Marian 26.86 %	25,932,042	26.86 %	17 M €
Gestys SA 0.0155 %	15,000	0.0155 %	10 052 €
UBS Wealth Management SGIIC SA 0.003211 %	3,100	0.003211 %	2 077 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 5.198 %	85,471	5.198 %	32 425 €

Name	Stocks	%	Valuation
Friedland Gestion SAS 4.167 %	64,103	4.167 %	19 950 €

List of AB SCIENCE shareholders

Company details: AB Science

AB Science SA

3, avenue George V

75008, Paris

+33 1 47 20 00 14

http://www.ab-science.com

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AB SCIENCE	-2.04%	-0.94%	-55.41%	-79.61%	48.31M
ELI LILLY AND COMPANY	-0.46%	+10.31%	+63.52%	+143.15%	1,257B
JOHNSON & JOHNSON	-0.97%	+1.60%	+43.25%	+80.09%	651B
ABBVIE INC.	-2.05%	+0.73%	+32.47%	+101.62%	510B
ROCHE HOLDING AG	-0.39%	-0.83%	+52.49%	+66.79%	388B
MERCK & CO., INC.	-0.78%	+5.51%	+72.55%	+44.25%	366B
NOVARTIS AG	+0.42%	+2.48%	+32.64%	+58.36%	303B
ASTRAZENECA PLC	-0.11%	+7.99%	+11.99%	+34.82%	288B
AMGEN INC.	-0.12%	+4.68%	+55.97%	+74.59%	252B
GILEAD SCIENCES, INC.	-0.21%	+7.34%	+42.19%	+109.69%	211B
Average	-0.66%	+4.30%	+35.17%	+63.37%	422.67B
Weighted average by Cap.	-0.66%	+5.30%	+49.17%	+93.62%